$0.44
-0.03 (-6.22%)
Open$0.46
Previous Close$0.47
Day High$0.47
Day Low$0.41
52W High$4.43
52W Low$0.43
Volume—
Avg Volume640.5K
Market Cap7.65M
P/E Ratio—
EPS$-10.37
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 13.40M | 11.60M | 1.76M |
| Net Income | -324,497,536 | -252,833,332 | -56,960 |
| Profit Margin | -2,421.8% | -2,300.7% | -3.2% |
| EBITDA | -293,256,752 | -241,185,970 | -70,729 |
| Free Cash Flow | — | — | -37,098 |
| Rev Growth | +15.5% | +15.5% | +11.5% |
| Debt/Equity | 0.37 | 0.37 | 0.30 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $217.49 | +2.05% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $351.85 | +0.82% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $139.37 | +2.22% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $446.54 | +0.76% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $772.64 | +3.12% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.87 | +4.68% | 139.7 | 43.84B |